Earnings Recaps

Browse reported earnings of the most popular stocks

Nov 21, 2026 Nov 20, 2026 Nov 19, 2026 Nov 18, 2026 Nov 17, 2026 Nov 15, 2026 Nov 14, 2026 Nov 13, 2026 Nov 12, 2026 Nov 11, 2026 Nov 10, 2026 Nov 9, 2026 Nov 8, 2026 Nov 7, 2026 Nov 6, 2026 Nov 5, 2026 Nov 4, 2026 Nov 3, 2026 Nov 2, 2026 Nov 1, 2026 Oct 31, 2026 Oct 30, 2026 Oct 29, 2026 Oct 28, 2026 Oct 27, 2026 Oct 26, 2026 Oct 25, 2026 Oct 24, 2026 Oct 23, 2026 Oct 22, 2026 Oct 21, 2026 Oct 20, 2026 Oct 19, 2026 Oct 18, 2026 Oct 17, 2026 Oct 16, 2026 Oct 15, 2026 Oct 14, 2026 Oct 13, 2026 Oct 11, 2026 Oct 10, 2026 Oct 9, 2026 Oct 8, 2026 Oct 7, 2026 Oct 3, 2026 Oct 2, 2026 Oct 1, 2026 Sep 30, 2026 Sep 29, 2026 Sep 27, 2026 Sep 26, 2026 Sep 25, 2026 Sep 24, 2026 Sep 23, 2026 Sep 19, 2026 Sep 18, 2026 Sep 17, 2026 Sep 16, 2026 Sep 14, 2026 Sep 13, 2026 Sep 12, 2026 Sep 11, 2026 Sep 10, 2026 Sep 9, 2026 Sep 8, 2026 Sep 5, 2026 Sep 4, 2026 Sep 3, 2026 Sep 2, 2026 Sep 1, 2026 Aug 31, 2026 Aug 30, 2026 Aug 29, 2026 Aug 28, 2026 Aug 27, 2026 Aug 26, 2026 Aug 25, 2026 Aug 23, 2026 Aug 22, 2026 Aug 21, 2026 Aug 20, 2026 Aug 19, 2026 Aug 18, 2026 Aug 17, 2026 Aug 16, 2026 Aug 15, 2026 Aug 14, 2026 Aug 13, 2026 Aug 12, 2026 Aug 11, 2026 Aug 10, 2026 Aug 9, 2026 Aug 8, 2026 Aug 7, 2026 Aug 6, 2026 Aug 5, 2026 Aug 4, 2026 Aug 3, 2026 Aug 2, 2026 Aug 1, 2026 Jul 31, 2026 Jul 30, 2026 Jul 29, 2026 Jul 28, 2026 Jul 27, 2026 Jul 26, 2026 Jul 25, 2026 Jul 24, 2026 Jul 23, 2026 Jul 22, 2026 Jul 21, 2026 Jul 20, 2026 Jul 19, 2026 Jul 18, 2026 Jul 17, 2026 Jul 16, 2026 Jul 12, 2026 Jul 11, 2026 Jul 10, 2026 Jul 9, 2026 Jul 3, 2026 Jul 2, 2026 Jul 1, 2026 Jun 30, 2026 Jun 28, 2026 Jun 27, 2026 Jun 26, 2026 Jun 25, 2026 Jun 24, 2026 Jun 20, 2026 Jun 19, 2026 Jun 18, 2026 Jun 17, 2026 Jun 15, 2026 Jun 14, 2026 Jun 13, 2026 Jun 12, 2026 Jun 11, 2026 Jun 10, 2026 Jun 9, 2026 Jun 6, 2026 Jun 5, 2026 Jun 4, 2026 Jun 3, 2026 Jun 2, 2026 Jun 1, 2026 May 31, 2026 May 30, 2026 May 29, 2026 May 28, 2026 May 27, 2026 May 26, 2026 May 24, 2026 May 23, 2026 May 22, 2026 May 21, 2026 May 20, 2026 May 19, 2026 May 18, 2026 May 17, 2026 May 16, 2026 May 15, 2026 May 14, 2026 May 13, 2026 May 12, 2026 May 11, 2026 May 10, 2026 May 9, 2026 May 8, 2026 May 7, 2026 May 6, 2026 May 5, 2026 May 4, 2026 May 3, 2026 May 2, 2026 May 1, 2026 Apr 30, 2026 Apr 29, 2026 Apr 23, 2026 Apr 22, 2026 Apr 21, 2026 Apr 20, 2026 Apr 18, 2026 Apr 17, 2026 Apr 16, 2026 Apr 15, 2026 Apr 14, 2026 Apr 13, 2026 Apr 10, 2026 Apr 9, 2026 Apr 8, 2026 Apr 7, 2026 Apr 2, 2026 Apr 1, 2026 Mar 31, 2026 Mar 30, 2026 Mar 26, 2026 Mar 25, 2026 Mar 20, 2026 Mar 19, 2026 Mar 18, 2026 Mar 17, 2026 Mar 16, 2026 Mar 13, 2026 Mar 12, 2026
22 companies Today

ams AG

AMSSY Q3 2026
Reported: 2026-11-17

Investors likely focused on the cautious Q4 outlook: ams-OSRAM expects revenue to decline sequentially and adjusted EBITDA margin to fall to 13%–15%, and the shares dropped 13.0% after the results. Q3 margin exceeded the midpoint of guidance, but performance was uneven, with consumer weakness and a sharp year-on-year decline in adjusted EBITDA.

Key takeaways
  • Q3 revenue was EUR 829 million, up 3% sequentially but down 3% year-on-year as divestments weighed on reported comparisons; the semiconductor core portfolio grew approximately 3% year-on-year on a like-for-like, constant-currency basis.
  • Adjusted EBITDA was EUR 135 million, with a 16.3% margin, above the midpoint of guidance but down 19% year-on-year; the company cited deconsolidation of noncore businesses, foreign exchange and raw material costs as headwinds.
  • Opto Semiconductors revenue rose 9% year-on-year to EUR 399 million, while LSP revenue fell 16% to EUR 227 million; excluding the divested business, LSP was down approximately 6%, mainly reflecting weakness in the Chinese smartphone market.
  • Consumer revenue declined 13% year-on-year amid weakness in the China Android market. By contrast, underlying Industrial & Medical revenue grew approximately 23%, and automotive grew approximately 4%.
  • The Q4 outlook calls for sequential revenue decline and an adjusted EBITDA margin of 13%–15%, below Q3’s 16.3% margin.

Bavarian Nordic A/S

BAVA.CO Q3 2026
Reported: 2026-11-17

Bavarian Nordic’s results and 2026 outlook were broadly steady, with shares down 0.2% after earnings. Travel Health growth and secured preparedness contracts supported the report, while the company flagged that its unusually high nine-month EBITDA margin reflects investment phasing, with more R&D and commercial spending expected in Q4.

Key takeaways
  • Nine-month revenue was just under DKK 4.9 billion, up 2% reported and more than 9% organically after adjusting for discontinued partnerships and foreign exchange.
  • Travel Health grew 24% in the first nine months and 22% in Q3; excluding discontinued partnerships, nine-month growth was over 30%, led by rabies and supported by Vimkunya.
  • Rabies sales in the U.S. market grew 36% in the first nine months versus the prior year, with management describing growth as accelerating.
  • Nine-month EBITDA margin was close to 35%, with management attributing part of the level to the phasing of R&D and commercial investments into Q4.
  • The company maintained its 2026 outlook: revenue of around DKK 6.1 billion, including approximately DKK 4 billion from Travel Health, and an EBITDA margin of around 32%; it also cited around DKK 2.4 billion secured for 2026 and DKK 900 million for 2027.

Compagnie Financiere Richemont SA

CFR.SW Q2 2027
Reported: 2026-11-17

Richemont’s shares fell 1.2% after interim results, a broadly positive but moderating sales picture: constant-currency growth eased to 13% in Q2 from 20% in Q1, while Asia Pacific growth slowed amid persistent softness in Mainland China. The move was within the roughly flat range, so the reaction does not indicate a sharp market disappointment.

Key takeaways
  • First-half sales rose 17% at constant exchange rates to €12.3 billion; Q2 growth was 13% against a 14% prior-year comparative.
  • Jewellery Maisons grew 19%, Specialist Watchmakers delivered double-digit growth, and the other business area recorded high-single-digit growth.
  • Regional growth was led by Japan (+30%), the Americas (+23%) and Asia Pacific (+16%). In China, Hong Kong and Macau combined, sales grew 7%, with Mainland China still soft.
  • Operating profit was €3.1 billion, including €229 million of positive tariff-related one-time items; excluding those items, profit was €2.9 billion, up from €2.4 billion a year earlier.
  • Operating cash flow was €2.5 billion and net cash reached €7.7 billion, after Richemont paid a €2.7 billion dividend in September.

Community

See what investors are trading, holding, and sharing

🌐
All
📈
Stock
📊
ETF
🏦
Mutual Fund
🪙
Crypto
💱
Forex
🥇
Commodities
# Asset Price Community % Type Currency Sector
Loading...